Back | Next |
home / stock / amrx / amrx message board
Subject | By | Source | When |
---|---|---|---|
$AMRX great article | dangerx | investorshub | 06/08/2023 4:00:04 AM |
$AMRX The gaining up | ListenToMe | investorshub | 06/05/2023 7:37:23 PM |
$AMRX Price gaining last up | ListenToMe | investorshub | 06/03/2023 11:57:56 PM |
Amarin Announces New REDUCE-IT Data. March 5, 2023. | Luckypennyman | investorshub | 03/07/2023 6:31:05 PM |
AMRX - Update | Jake L | investorshub | 08/26/2021 1:04:11 AM |
monster bio beast ready to beast in beast land!! | TrendTrade2016 | investorshub | 03/09/2021 7:58:05 PM |
* * $AMRX Video Chart 03-08-2021 * * | ClayTrader | investorshub | 03/08/2021 8:55:52 PM |
$AMRX is a good long term hold. | ListenToMe | investorshub | 01/13/2021 12:26:30 PM |
I was hoping $AMRX would have better news | ListenToMe | investorshub | 01/06/2021 12:50:35 PM |
Any opinions on $AMRX for 2021? | ListenToMe | investorshub | 01/02/2021 6:22:40 PM |
$AMRX... the time will come.! | ListenToMe | investorshub | 12/28/2020 12:40:50 AM |
Looks like amrx is going into the 3's | ListenToMe | investorshub | 12/14/2020 3:56:56 AM |
I agree $AMRX needs a good catalyst to | ListenToMe | investorshub | 11/28/2020 3:11:51 PM |
Its a fantastic play, its just theyre in | Elpapibh | investorshub | 11/27/2020 8:15:31 PM |
I'm still thinking $AMRX will be a great | ListenToMe | investorshub | 11/26/2020 9:44:22 PM |
$AMRX is getting a little bounce today. nice | ListenToMe | investorshub | 11/23/2020 4:24:23 PM |
No demand, yet | Elpapibh | investorshub | 11/19/2020 8:51:59 PM |
I'm really surprised this thing isn't 4X Higher. | ListenToMe | investorshub | 11/16/2020 12:39:42 PM |
Close to 2 bil market cap no reason | Elpapibh | investorshub | 11/06/2020 8:30:44 PM |
Lets see what these earnings dooo | Elpapibh | investorshub | 11/05/2020 8:52:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Amneal Pharmaceuticals Inc. Class A Company Name:
AMRX Stock Symbol:
NYSE Market:
Amneal Pharmaceuticals Inc. Class A Website:
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its second quarter 2024 financial results on Friday, August 9, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time. ...
FOCINVEZ (fosaprepitant) 150 mg/50 mL single dose vial is an anti-nausea agent for highly emetogenic and moderately emetogenic chemotherapy (HEC and MEC) Second injectable RTU product launched by Amneal in 2024 Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal”...
Builds on successful U.S. biosimilar partnership of 2 oncology products (RELEUKO ® & FYLNETRA ® ) ADL018 is Kashiv’s lead pipeline biosimilar program, currently in Phase III Kashiv BioSciences, LLC (“Kashiv” or the “Companyȁ...